Chapter 37: Disorders of the Vascular System

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Imagine like just walking one block to your mailbox and suddenly your calf muscle just begins to scream in agony,

almost as if you've just run a marathon.

You have to stop, lean against a fence and just wait for the burning to subside before you can even take another step.

Because for millions of patients, I mean, this isn't a muscle tear, it's not a cramp.

It's a massive traffic jam right inside their arteries.

It's terrifying for the patient and it brings up this really fascinating clinical paradox.

How does the body's innate attempt to heal a tiny micro injury inside a blood vessel end up basically paving over the entire lumen?

Right, until the limb is just completely starved of oxygen.

Exactly.

Well, that is the exact mystery we are unpacking today.

Welcome to the Deep Dive.

We were doing a really special clinical mastery session for you, the advanced practice nursing student.

So whether you are prepping for your clinical rotations or, you know, staring down your upcoming boards, our mission today is to master Chapter 37.

Disorders of the vascular system.

Yes.

We are synthesizing the current clinical guidelines and literature on vascular disorders into actionable clinical reasoning.

So we're translating the science into safe, patient -centered management.

And we'll be focusing really heavily on the mechanisms here.

Yeah.

Because once you understand the why and the how of a disease, like what is structurally happening at the cellular level, everything else just falls into place.

Right, the assessment, the differential diagnosis.

Yeah, and the pharmacological interventions.

They all just logically make sense.

You don't have to memorize a random list of symptoms if you just understand the underlying plumbing.

I love that.

Okay, let's unpack this.

We're going to cover two main plumbing systems today, right?

The delivery lines and the return lines.

Let's jump right into the high -pressure delivery side first.

When a patient reports that severe grabbing, cramp -like pain in their calf that forces them to stop walking, we are looking at peripheral artery disease, or PAD.

Yeah, and the foundational culprit there is atherosclerosis.

Right.

Which, it starts as just a microscopic injury, doesn't it?

It does.

The endothelial lining of the artery gets damaged, maybe from hypertension or smoking or circulating toxins, and the body tries to heal that injury by sending macrophages to the site.

Those macrophages, they consume circulating LDL cholesterol, they transform into these things called foam cells, and they embed themselves right in the arterial wall.

Wow.

And over time, this creates a fatty streak that just calcifies into a hard arteriosclerotic plaque, which literally narrows the artery.

I always think of this like a busy two -lane highway that gets reduced down to a single lane because of construction.

That's a perfect analogy.

Right.

Like in the middle of the night when traffic is super light, cars get through just fine, that is your patient at rest.

The baseline blood flow is enough to keep the tissue alive.

Exactly.

But during rush hour, so when your patient starts walking or climbing stairs, the leg muscles suddenly demand a massive increase in oxygen.

And those muscles release local metabolites, right, signaling for arterial vasodilation to increase that flow.

But PD leaves those arteries stiff, calcified, and just completely unable to dilate.

So the narrowed artery just can't accommodate the demand.

Right.

It causes a severe bottleneck.

Because the muscle tissue isn't getting oxygen, it's forced to switch from aerobic to anaerobic metabolism.

And a byproduct of anaerobic metabolism is lactic acid.

Yes.

That buildup of lactic acid in the muscle tissue is exactly what causes the intense burning and cramping.

It's the physiological mechanism behind intermittent claudication.

Okay, so when the patient rests, the oxygen demand drops, the blood flow catches up, and the lactic acid is cleared out.

And the pain resolves.

But as that plaque buildup worsens, it takes less and less exertion to trigger the pain until eventually the limb is so starved of oxygen that the patient experiences pain even while just resting in bed.

Oh, wow.

So rest pain is a major red flag indicating critical limb ischemia.

Absolutely.

And we see this progression accelerate dramatically in patients with diabetes, don't we?

Like if you are managing a diabetic patient, their risk profile for PAD is exponentially higher.

Oh, without a doubt.

The disease often presents much more aggressively.

The cellular impact of chronic hyperglycemia is just profound.

High blood sugar causes the formation of advanced glycation end products or AGs.

Right, AGs.

And these compounds directly damage the endocallial lining and promote rampant oxidative stress.

And crucially, in diabetic patients, this whole systemic inflammatory process heavily targets the smaller caliber arterial vessels first.

So the most distal regions of the lower extremities.

Exactly.

Which perfectly explains why we see such devastating outcomes in the feet of diabetic patients.

It's not just diabetic neuropathy dulling their sensation of a wound.

Right, it's a profound delivery issue.

The microscopic plumbing at the very end of the line, like the capillary beds in the toes, is completely choked off.

So moving into the clinical presentation, your objective assessment for PAD relies heavily on palpation.

You are checking bilateral pulses.

Right, femoral, popliteal, dorsalis pitus, and posterior tibial, using that standard grading scale.

Right.

Zero is absent, one plus is diminished, two plus is normal, and three plus is bounding.

Oh wait, let me pose a real world scenario here.

High four.

Let's say I'm in the clinic, right?

I'm palpating a completely healthy 25 -year -old's foot, and I just simply cannot find a dorsalis pitus pulse.

Like, does an absent pulse automatically mean I'm diagnosing PD?

Oh, that is a critical clinical reasoning check right there.

An absent pulse does not guarantee disease.

Okay.

The literature actually notes that roughly 10 % of the healthy population naturally lacks palpable pedal pulses just due to anatomical variation.

Oh wow, 10%.

So you cannot base a vascular diagnosis on a single isolated finding.

You have to look for the systemic signs of arterial ischemia.

And this is where we look for the classic six P's, right?

Pain,

pulselessness, paresthesia, which is, you know, that numb pins and needles feeling from the ischemic nerves, paralysis, piculothermia, which means the limb feels cool to the touch because it lacks warm arterial blood and pallor.

Yep.

The skin appears pale or mottled.

Yeah.

And you can actually actively demonstrate this ischemia right in the exam room using the leg elevation test.

How does that work?

You basically have the patient lie supine and you elevate their legs to about 60 degrees for a minute.

A limb with severe PA will quickly turn pale white.

Because the narrowed arteries can't pump uphill against gravity.

Exactly.

Then you have the patient sit up and dangle their legs over the side of the exam table.

Gravity suddenly pulls whatever blood it can down into those oxygen -starved vessels.

And the leg turns a dusky, deep, purplish red.

Yes.

That phenomenon is called dependent ruber.

Okay.

So once your physical assessment points toward PAD, you need to confirm the diagnosis objectively.

And the gold standard for initial non -invasive testing is the Doppler ultrasound flow study.

Specifically calculating the ankle brachial index, the ABI.

Right.

The ABI.

I always think of the ABI like checking the plumbing in a two -story house.

If you measure the water pressure at the main valve downstairs, it should be pretty strong.

Sure.

But if you go upstairs to the shower head and it's just a weak trickle, you know there is a major blockage somewhere between the first and second floor.

The ABI does the exact same thing, just with systolic blood pressure.

That's a great way to look at it.

You basically use a blood pressure cuff and a handheld Doppler to measure the systolic pressure in the ankle, and you divide it by the systolic pressure in the arm.

Okay.

In a healthy system, the pressure in the legs should be equal to or even slightly higher than the arms.

So a normal ABI ratio is greater than 0 .9.

But if there is an atherosclerotic roadblock in the leg, the pressure drops significantly by the time the blood actually reaches the ankle.

Exactly.

An ABI reading between 0 .6 and 0 .9 indicates moderate peripheral artery disease.

If that ratio drops below 0 .5, you are looking at severe ischemia.

So the circulation in the leg is profoundly compromised at that point.

Now we transition into evidence -based management.

The guidelines mandate that patients with symptomatic PAD be started on antiplatelet therapy.

Typically, this is a daily aspirin or clopidogrel, which we know is Plavix.

Yep.

75 milligrams daily.

But we have to be super clear with our patient education here.

Like, if you prescribe Plavix, will this cure their leg pain?

No.

And that is a vital distinction.

Antiplatelet agents do not provide any measurable improvement in the physical symptoms of claudication.

Okay.

So why take them?

We prescribe them to mitigate a systemic threat.

If a patient's peripheral arteries are severely calcified, you know, their coronary and cerebral arteries are undoubtedly compromised too.

We are trying to prevent a concurrent myocardial infarction or an ischemic stroke.

That makes sense.

And just a quick note on the literature regarding newer antiplatelets.

You might read about ticogrelor.

A massive trial actually showed that it offers no statistical benefit over clopidogrel for PAD.

Right.

So stick to aspirin or Plavix.

And ensure they are on a high intensity statin to stabilize those plaques.

But wait, that still leaves us with a patient whose leg pain is basically ruining their quality of life.

What about symptom management?

For symptoms, the guidelines recommend a medication called psilostazol, brand name Pletil.

It's a phosphodiesterase 3 inhibitor.

By increasing intracellular cyclic AMP,

it promotes smooth muscle relaxation, causing vasodilation.

It also inhibits platelet aggregation.

Opening those vessels directly increases walking distance and reduces that claudication pain.

But, and this is huge, you must run a strict scope of practice and safety check before you write that prescription.

You must never prescribe psilostazol to a patient with a history of heart failure.

Yes.

Absolutely never.

It is a black box warning.

Clinical trials have demonstrated that oral phosphodiesterase 3 inhibitors actually decrease survival rates in patients with congestive heart failure.

So, always reconcile the cardiac history before initiating symptom management for PAD.

Always.

Since pharmacology has limits, we rely heavily on non -pharmacologic interventions to promote health, right?

Like the Burger Allen exercises.

Yes.

The patient lies flat, elevates their legs to a 45 -degree angle until the skin turns pale, lowers them below the body until they turn red, and then rests flat.

And they repeat this cycle multiple times a day.

Basically using gravity as a mechanical pump to train the microvascular system.

We also pair this with a supervised treadmill walking program.

Oh, this is the one where we literally instruct the patient to walk on a treadmill until they feel moderate claudication pain, right?

Yes, walk until it hurts, then stop and rest until the pain subsides, and then immediately resume walking.

They do this for 30 to 45 minutes, three times a week.

I mean, it sounds incredibly harsh to tell a patient to intentionally walk until it hurts.

It does, but the physiological payoff is amazing.

The intermittent ischemia caused by pushing the muscle to the point of pain triggers the release of vascular endothelial growth factor.

Ah, so the body senses the lack of blood flow and responds.

Exactly.

It grows entirely new microscopic collateral blood vessels right around the atherosclerotic blockages.

The body builds its own organic bypasses.

That is so cool.

And finally, you must educate the patient on meticulous daily foot care.

Because their distal perfusion is so poor, a tiny blister can quickly evolve into an arterial ulcer.

Yeah, and these ulcers typically look perfectly round, almost as if they were like punched out of the skin, usually on the toes or the lateral malleolus.

Right.

So patients should inspect their feet daily with a mirror, never walk barefoot,

wear well -fitting shoes and avoid soaking their feet.

Right, because soaking can macerate that fragile skin.

Okay, so that covers the high pressure delivery failure.

Now we look at the other side of the equation.

What happens when the delivery is fine, but the low pressure return system fails?

Deep vein thrombosis and chronic venous insufficiency.

Yes.

If Pead is a problem of arteries starving the tissue, venous disorders are a problem of blood becoming trapped and flooding the tissue.

Exactly.

And the acute life -threatening manifestation of this is a deep vein thrombosis, or DDT.

The foundational pathophysiology here is governed by Virchow's triad.

Which is three distinct conditions that create the perfect storm for clot formation, right?

Venous stasis, endothelial injury, and a hypercoagulable state.

A lot of clinicians use the mental model of stagnant water, damaged riverbanks, and sticky water to conceptualize Virchow's triad.

I like that.

Let's look at the mechanisms behind that.

Venous stasis, the stagnant water, happens when blood simply sits still in the lower extremities.

Without the skeletal muscles contracting to pump the blood upward, it pools.

Especially around those delicate valve cusps in the deep veins of the calf.

This is why prolonged immobility, like a patient on strict bed rest or someone taking a 14 -hour international flight, is a major risk factor.

Makes sense.

Next is endothelial injury, the damaged riverbanks.

Direct trauma to the vein exposes the subendothelial collagen.

Which instantly triggers the body's clotting cascade.

We see this constantly in post -operative patients.

Orthopedic procedures like hip replacements or knee reconstructions involve massive tissue manipulation and bone trauma.

Putting those patients at extreme risk.

And the third factor is hypercoagulability, the sticky water.

The blood itself chemically alters to become more prone to clotting.

Right.

This can be driven by active malignancies or inherited coagulation disorders like Factor V Leiden.

But in primary care, you will frequently see hypercoagulability driven by high estrogen states.

Because estrogen increases the hepatic production of coagulation factors?

So patients on oral contraceptives, hormone replacement therapy, or women in the prenatal and postpartum periods are highly susceptible.

I mean, pregnancy alone increases the risk of a DVT fivefold.

Wow.

And a clot sitting quietly in the deep veins of the calf might seem isolated.

But the real terror is what happens if that clot becomes unstable.

It propagates, grows larger, and eventually embolizes.

It breaks free from the vessel wall, rides the venous return up the inferior vena cava, passes through the right side of the heart, and shoots directly into the pulmonary arterial circulation.

Lodging right in the lungs, creating a pulmonary embolism.

Yes.

The lungs are ventilating, bringing in oxygen.

But the blood flow is completely blocked.

It creates a massive ventilation -perfusion mismatch.

The literature notes that sudden cardiac death is the first and only symptom in about a quarter of people who suffer a massive PE.

That is terrifying.

And the danger isn't even limited to the lungs.

Like if a patient has an anatomical quirk like a patent form in oval, a small hole between the right and left atria of the heart,

the clot can bypass the pulmonary system entirely.

Yep.

It crosses over the left side of the heart, gets pumped out into the systemic circulation, travels up the carotid arteries, and causes an ischemic stroke.

Because the stakes are so high, our assessment and clinical reasoning have to be razor sharp.

But subjectively, the symptoms of a DVT can be really vague, right?

Frighteningly vague.

Many lower extremity thrombi are entirely asymptomatic.

When symptoms do appear, the patient usually just reports a dull ache or muscle tenderness in the calf.

Objectively, you might observe unilateral edema -like, one leg is measurably larger in circumference than the other.

The limb might feel warm, or the patient might have a low -grade fever.

Right.

And you might have older textbooks telling you to test for Hohmann's sign.

Oh, right.

Forcefully bending the patient's foot backward into dorsiflexion to see if it causes calf pain.

Don't do it.

The current guidelines are emphatic that Hohmann's sign is an outdated and unreliable diagnostic tool.

It lacks any meaningful specificity, doesn't it?

Exactly.

A torn muscle, a ruptured Baker's cyst, or simple Achilles tendonitis can all trigger a positive Hohmann's sign.

It is not safe or accurate for clinical decision making.

Okay.

So instead, your diagnostic algorithm should start with a clinical probability assessment model, specifically the Wells Criteria.

Yes.

This tool assigns points based on active risk factors.

Does the patient have active cancer?

Is the entire leg swollen?

Is there localized tenderness?

And the cumulative score categorizes the patient as having a low, intermediate, or high probability of a DVT.

Right.

Now, if the Wells score categorizes the patient as low probability, you might order a D -dimer blood test.

D -dimer is a breakdown product of fibrin, so if your body is actively dissolving a blood clot somewhere, D -dimer levels will be elevated.

I always compare the D -dimer to a highly sensitive smoke detector.

If it doesn't beat, you can sleep soundly.

You know there is absolutely no fire in the house.

That perfectly illustrates its high sensitivity.

A negative D -dimer in a low probability patient safely rules out a DVT.

Yeah.

But it has incredibly low specificity.

Meaning a positive D -dimer does not confirm a DVT.

Exactly.

Many physiological stressors cause elevated fibrin degradation, advanced age, a recent surgery, pregnancy, or even a severe systemic infection.

It just means the smoke detector went off.

It might just be burnt toast.

Exactly.

So if your patient has an intermediate or high Wells score right off the bat, you skip the D -dimer entirely.

You know it will likely be elevated anyway from concurrent issues.

Omar, so you proceed directly to the diagnostic gold standard.

Compression ultrasonography of the femoral and popliteal veins?

Yes.

The ultrasound technician presses the transducer probe directly into a leg.

A healthy patent vein will compress completely under the pressure.

If a DVT is present, the vein remains rigid and non -compressible because a solid thrombus is occupying the lumen.

Okay.

So once the diagnosis is confirmed, we initiate management.

The cornerstone of DVT therapy is systemic anticoagulation to prevent the clot from propagating while the body's natural system dissolves it.

Historically, patients were hospitalized on an IV heparin drip and transitioned to oral warfarin, brand name Coumadin.

Right.

Warfarin is a vitamin K antagonist, but it presents a massive management burden.

It does.

It requires rigorous ongoing blood monitoring using the PTI and R test to ensure the blood isn't too viscous or too dangerously thin.

Plus, patients have to maintain a perfectly consistent dietary intake of vitamin K found in leafy greens.

Because fluctuations will wildly alter the drug's efficacy.

Right.

So current clinical guidelines now favor treating stable patients in the outpatient setting using direct oral anticoagulants or DOACs.

These include factor ZEA inhibitors like apixaban and rivaroxaban or direct thrombin inhibitors like Dabigatran.

The clinical advantage of DOACs is that they do not require routine PTNR laboratory monitoring and they don't have the strict dietary restrictions of warfarin.

You just prescribe a fixed standard dose.

However, advanced practice nurses must educate patients to avoid NSAIDs, excessive alcohol, and over -the -counter supplements like ginkgo biloba or high -dose vitamin E, which compound the bleeding risk.

Very true.

And for patients who have an absolute contraindication to anticoagulants, maybe they have an active gastrointestinal bleed or recently underwent neurosurgery, we utilize a mechanical intervention.

A vena cava filter.

Yes.

An interventional radiologist places it.

It is literally a tiny metallic basket deployed in the inferior vena cava to physically catch and trap embolized clots before they can reach the lungs.

Now when we talk about preventing DVT in high -risk patients, we utilize intermittent pneumatic compression devices.

These sleeves wrap around the legs and sequentially inflate and deflate.

Right.

Mimicking the pumping action of the calf muscles, preventing venous stasis.

But this brings us to a critical nursing safety intervention.

If you are caring for a patient who has a known active DVT,

you must absolutely never apply pneumatic compression devices to that affected limb.

It is an absolute contraindication.

Mechanically massaging or forcefully compressing a vein that contains an active unstable thrombus is a guaranteed way to dislodge that clot and induce a fatal pulmonary embolism.

So for a patient with an active DVT, your interventions are strictly to elevate the affected limb, apply warm compresses to relieve pain, and limit vigorous activity until the anticoagulants stabilize the thrombus.

Exactly.

So we've covered what happens when a massive clot forms, but what happens if the venous valve simply degrade and wear out over decades of standing and working?

That leads us to our final core concept, chronic venous insufficiency, or CVI.

Veins rely on delicate, one -way leaflet valves to push blood upward against gravity.

In CVI, those valves become permanently incompetent.

They stretch out, lose their tight seal, and just allow retrograde blood flow.

Yeah, the blood physically falls backward down the leg.

So the physical assessment of CVI is fundamentally the opposite of PDE.

With arterial disease, the limb is starved, cool, pale, and pulseless.

With venous insufficiency, the blood is trapped.

Right.

The limb is warm, pulses are present but often difficult to palpate due to massive, dependent edema, and the superficial veins distend into tortuous varicose veins.

And as the hydrostatic pressure builds inside the lower extremities, red blood cells are physically forced out of the high -pressure capillaries into the surrounding tissue.

And macrophages break down those escaped red blood cells, leaving behind iron deposits called hemosyterin.

This causes a classic defining sign of advanced CVI stasis dermatitis.

Which presents as that distinct leathery, brownish hyperpigmentation of the lower legs.

Yep.

And over time, the chronic edema and poor tissue oxygenation cause the skin to break down completely, resulting in broad, weeping venous ulcers.

Unlike the perfectly round arterial ulcers on the toes, venous ulcers typically have irregular borders and form higher up.

Usually around the medial malleolus or the inner ankle.

And because CVI is a permanent, structural mechanical failure of the valves, our management strategies are highly conservative and non -pharmacologic.

We are using external forces to replicate the job the valves can no longer do.

So we prescribe gradient compression stockings, which apply the highest pressure at the ankle to physically force fluid back up the leg.

We encourage weight loss to reduce intra -abdominal pressure.

And we instruct the patient to elevate their legs above the level of their heart for at least 30 minutes, multiple times a day.

Utilizing gravity to drain the pooled blood.

And you must be highly cautious with pharmacology here.

When you see a patient with massive lower extremity edema, the instinct might be to

loop diuretic to pull off that fluid.

Right.

But the guidelines explicitly advise against this.

Yes.

Diuretics are not indicated for CVI edema unless the patient has a compounding comorbid condition like acute heart failure or severe renal dysfunction.

Administering a systemic diuretic for localized venous pooling will simply dehydrate the patient intravascularly without fixing the underlying valvular incompetence.

Well, what an incredible journey through the body's plumbing.

To quickly summarize our clinical mastery session, arterial disease, or PA, is a failure of high pressure delivery.

Presenting with cool, pale, painful limbs driven by ischemia,

managed aggressively with antiplatelets, statins, and supervised walking programs to build collateral flow.

While venous disease, encompassing DBT and CVI, is a failure of low pressure return.

Presenting with warm, swollen legs from pooled blood, managed with systemic anticoagulants, elevation, and external compression.

Beautiful.

And as you synthesize all of this literature for your exams and clinical practice, consider where the science is heading next.

We currently treat these devastating vascular disorders with structural patches, dents, and rheological drugs like blood thinners.

But researchers are actively exploring mRNA therapeutics and targeted CRISPR gene therapies designed to induce localized angiogenesis.

Imagine a future where, instead of forcing a patient to walk through ischemic pain to grow new vessels.

We can genetically program the tissue to build its own biological bypasses before the limb is ever truly starved.

Wow.

The future of advanced practice vascular medicine is going to be remarkable.

I cannot wait to see those guidelines hit the literature.

To the advanced practice student listening, you have got this.

We have unpacked the cellular pathophysiology, the diagnostic reasoning, and the safe, evidence -based management of these incredibly complex systems.

Thank you for studying with the Last Minute Lecture Team.

Keep up the great work, trust your clinical reasoning, and we'll see you on the next deep dive.